Cargando…
Plasma miR-323 as a Biomarker for Screening Papillary Thyroid Cancer From Healthy Controls
The present study aims to evaluate whether plasma miR-323 serves as a potential biomarker to screen patients with papillary thyroid cancer (PTC) from healthy controls. Real-time PCR was performed to evaluate miR-323 expression in healthy controls and benign thyroid nodule (BTN) and PTC patients. Rec...
Autores principales: | Liu, Yang, Li, Lin, Liu, Zheng, Yuan, Qingling, Lu, Xiubo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242560/ https://www.ncbi.nlm.nih.gov/pubmed/32478079 http://dx.doi.org/10.3389/fmed.2020.00122 |
Ejemplares similares
-
MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer
por: Dai, Lei, et al.
Publicado: (2017) -
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
por: Qiu, Shuwei, et al.
Publicado: (2013) -
Serum miR-22 may be a biomarker for papillary thyroid cancer
por: Wang, Deping, et al.
Publicado: (2019) -
Long Non-coding RNA EBLN3P Regulates UHMK1 Expression by Sponging miR-323a-3p and Promotes Colorectal Cancer Progression
por: Xu, Xiang-hao, et al.
Publicado: (2021) -
Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas
por: Jiang, Ke, et al.
Publicado: (2020)